O
YI

OrbiMed’s 111 Inc YI Stock Holding History

OrbiMed’s Portfolio YI Stock Details YI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-50,000
Closed -$3.07M – 143
2018
Q4 		$3.07M Hold
50,000
– – 0.06% 113
2018
Q3 		$6.76M Buy
+50,000
New +$6.99M 0.08% 121

Other funds holding YI

CIM
Chiron Investment Management New York $300M AUM 49.09% 1-Year Est. Return
GAM
Greenwoods Asset Management Grand Cayman, Cayman Islands $4.35B AUM 149.74% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
TPM
Totem Point Management New York $78.4M AUM 88.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EMR
Errol M. Rudman $148M AUM 19.65% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

OrbiMed's YI Position: Q1 2019 in Review

OrbiMed sold out of 111 Inc (YI) in Q1 2019, closing a stake of 50,000 shares — an estimated $3.07M sold.

OrbiMed first reported a position in YI in Q3 2018 and held it in 2 quarters. The position peaked at $6.76M in Q3 2018. 10 funds tracked by Wall St. Rank hold YI as of Q1 2019.

  • OrbiMed reported no remaining 111 Inc position as of Q1 2019 after selling out during the quarter.
  • OrbiMed sold 50,000 111 Inc shares in Q1 2019, an estimated $3.07M.
  • OrbiMed first reported a position in 111 Inc in Q3 2018 and held it in 2 quarters.
  • OrbiMed's 111 Inc position peaked at $6.76M in Q3 2018.
  • 10 funds tracked by Wall St. Rank held 111 Inc as of Q1 2019.

Based on OrbiMed's 13F filing for Q1 2019, filed 15 May 2019.